Garret A FitzGerald

Title: Garret A FitzGerald: Innovator in Cardiovascular Research

Introduction

Garret A FitzGerald is a prominent inventor based in Wayne, PA (US). He has made significant contributions to the field of cardiovascular research, holding a total of 5 patents. His work focuses on the development of innovative methods and compositions that assess cardiovascular risk.

Latest Patents

FitzGerald's latest patents include a prostaglandin D metabolite and its derivatives, which are designed for use in compositions and antibodies that specifically bind to the metabolite. Additionally, he has developed methods for assessing cardiovascular risk using isoprostane biomarkers and COX-2 selective inhibitors. These methods utilize biomarkers, including prostanoid metabolites and isoprostanes, as sensitive and stable markers of cardiovascular risk, particularly in mammals undergoing various therapies.

Career Highlights

Throughout his career, FitzGerald has worked with esteemed institutions, including the University of Pennsylvania. His research has significantly advanced the understanding of cardiovascular health and risk assessment.

Collaborations

FitzGerald has collaborated with notable colleagues such as Joshua Rokach and Domenico Pratico, contributing to the advancement of cardiovascular research through shared expertise and innovative ideas.

Conclusion

Garret A FitzGerald's contributions to cardiovascular research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact the assessment and management of cardiovascular risk.